We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 3584P
InnovaDerma PLC
09 October 2019
InnovaDerma PLC
("InnovaDerma" or the "Company")
Notice of Annual General Meeting & Posting of Annual Report and Accounts
InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, announces that it has today posted its Annual Report and Accounts for the year ended 30 June 2019 to shareholders, together with the Notice of the Company's Annual General Meeting ("AGM") and the Form of Proxy. These documents will be available shortly for download on the Company's website, http://www.innovaderma.com/company-publications/.
The AGM will be held at finnCap Ltd, 60 New Broad Street, London EC2M 1JJ on 6 November at 10am (GMT).
Further enquiries
InnovaDerma Haris Chaudhry/Joe Bayer +61 (0)3 9863 8030 Kieran Callan (c/o TB Cardew) +44 (0)20 7930 0777 finnCap Ltd Geoff Nash/Giles Rolls/Kate +44 (0)207 220 0500 Bannatyne www.finncap.com Alice Lane - Corporate Broking --------------------------- TB Cardew Shan Willenbrock/Tom Allison +44 (0)20 7930 0777 Olivia Rosser innovaDerma@tbcardew.com ---------------------------
About InnovaDerma:
InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in life sciences, beauty and personal care products. InnovaDerma has presence in Europe, US, Australasia, North Asia and Africa.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCQKLFBKBFFFBL
(END) Dow Jones Newswires
October 09, 2019 12:14 ET (16:14 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions